
Is Dose-Dense Paclitaxel Better than Every-Three-Week Paclitaxel in Ovarian Cancer?
Author(s) -
Rabiya S. Tuma
Publication year - 2009
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000365303.19214.9f
Subject(s) - paclitaxel , ovarian cancer , oncology , medicine , cancer